These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 501086)
1. Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats. Fish DC; Djurickovic DB; Huebner RJ J Immunol; 1979 Dec; 123(6):2658-63. PubMed ID: 501086 [TBL] [Abstract][Full Text] [Related]
2. Prevention of tumors in rats by cross-protective immunization. Fish DC; Bare AL; Djurickovic DB; Huebner RJ J Natl Cancer Inst; 1981 Nov; 67(5):1041-51. PubMed ID: 6946246 [TBL] [Abstract][Full Text] [Related]
3. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy. Genovesi EV; Pettey CL; Collins JJ Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan. Mizushima Y; Sendo F; Takeichi N; Hosohawa M; Kobayashi H Cancer Res; 1981 Jul; 41(7):2917-21. PubMed ID: 6454480 [TBL] [Abstract][Full Text] [Related]
5. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma. Bernstein ID J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744 [TBL] [Abstract][Full Text] [Related]
6. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats. Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719 [TBL] [Abstract][Full Text] [Related]
7. In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity. Glaser M; Lavrin DH; Herberman RB J Immunol; 1976 Jun; 116(6):1507-11. PubMed ID: 58036 [TBL] [Abstract][Full Text] [Related]
8. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells. Lukacs K; Kurlander RJ J Immunol; 1989 Dec; 143(11):3731-6. PubMed ID: 2479688 [TBL] [Abstract][Full Text] [Related]
9. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages. Harmel RP; zbar B J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729 [TBL] [Abstract][Full Text] [Related]
10. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment. Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. Suzuki F; Schmitt DA; Utsunomiya T; Pollard RB In Vivo; 1992; 6(6):589-96. PubMed ID: 1296807 [TBL] [Abstract][Full Text] [Related]
12. Immunophenotypical changes of neoplastic cells and tumor-associated macrophages in a rat dendritic cell sarcoma-derived transplantable tumor line (KB-D8). Kawashima M; Ide M; Nakanishi M; Kuwamura M; Kumagai D; Yamate J Virchows Arch; 2003 Feb; 442(2):141-50. PubMed ID: 12596065 [TBL] [Abstract][Full Text] [Related]
13. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
14. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus. Sharma JM; Herberman RB; Djeu JY; Nunn ME J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590 [No Abstract] [Full Text] [Related]
16. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma. Morikawa K; Hosokawa M; Hamada J; Xu ZY; Kobayashi H Cancer Res; 1986 Feb; 46(2):684-8. PubMed ID: 2416431 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial cells in cell-mediated immunity: adoptive transfer with in vitro conditioned cells is genetically restricted at the endothelial cell barrier. Standage BA; Vetto RM; Jones R; Burger DR J Cell Biochem; 1985; 29(1):45-56. PubMed ID: 4055922 [TBL] [Abstract][Full Text] [Related]
18. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals. Henderson LA; Ciavarra R; Riblet R; Forman J J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids. Dillehay DL; Shealy YF; Lamon EW Cancer Res; 1989 Jan; 49(1):44-50. PubMed ID: 2783245 [TBL] [Abstract][Full Text] [Related]
20. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs. de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]